We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Intelligent Ultrasound Group Plc | LSE:MED | London | Ordinary Share | GB00BN791Q39 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 14.50 | 14.00 | 15.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMMED
RNS Number : 3899K
Intelligent Ultrasound Group PLC
28 August 2019
28 August 2019
Intelligent Ultrasound Group plc
("Intelligent Ultrasound" or the "Company")
Director Dealings
Intelligent Ultrasound (AIM: MED), the intelligent ultrasound software and simulation company, announces that further to the Company's announcements on 8 August 2019 and 27 August 2019, certain Directors have, following Admission today, acquired a total of 500,000 Ordinary Shares in the Company ("Ordinary Shares") via the Placing, as detailed below:
Percentage Number Value of enlarged of Placing of Placing Resultant share Shares Shares shareholding capital subscribed subscribed following following Name Title for# for# subscription# subscription# ----------------- ------------------ ------------ ------------ --------------- --------------- Chief Executive Stuart Gall Officer 200,000 GBP20,000 828,236 0.38% Wilson Jennings Finance Director 100,000 GBP10,000 394,118 0.18% Chief Technology Nicholas Sleep Officer 100,000 GBP10,000 326,471 0.15% Chief Operating Ian Whittaker Officer 25,000 GBP2,500 374,982 0.17% Non-Executive Nick Avis Director 25,000 GBP2,500 225,000 0.10% Non-Executive Nazar Amso Director 50,000 GBP5,000 1,134,000 0.52%
In addition to the above:
Professor Nazar Amso is the beneficial holder of 180,000 Ordinary Shares through The Amso Trust and Professor Nazar Amso's spouse holds 120,000 Ordinary Shares.
# The number of Ordinary Shares presented in this table as being held or subscribed for by Directors refers to the number of Ordinary Shares held or subscribed for by them either personally or through a nominee.
Unless otherwise defined herein, capitalised terms used in this announcement shall have the same meanings as defined in the circular sent to shareholders of the Company on 8 August 2019.
The Company makes the following disclosures in accordance with article 19(3) of the Market Abuse Regulation:
1 Details of the person discharging managerial responsibilities / person closely associated a) Name 1. Stuart Gall 2. Wilson Jennings 3. Nicholas Sleep 4. Ian Whittaker 5. Nick Avis 6. Nazar Amso --------------------------- ----------------------------------- 2 Reason for the notification ---------------------------------------------------------------- a) Position/status 1. Chief Executive Officer 2. Finance Director 3. Chief Technology Officer 4. Chief Operating Officer 5. Non-Executive Director 6. Non-Executive Director --------------------------- ----------------------------------- b) Initial notification Initial /Amendment --------------------------- ----------------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ---------------------------------------------------------------- a) Name Intelligent Ultrasound Group plc --------------------------- ----------------------------------- b) LEI 213800K4ZVWL4ZYQAZ70 --------------------------- ----------------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted ---------------------------------------------------------------- a) Description of the Ordinary Shares of 1 pence each financial instrument, type of instrument ISIN: GB00BN791Q39 Identification code --------------------------- ----------------------------------- b) Nature of the transaction Purchase of Ordinary Shares --------------------------- ----------------------------------- c) Price(s) and volume(s) Price(s) Volume(s) 1. 10 pence 1. 200,000 2. 10 pence 2. 100,000 3. 10 pence 3. 100,000 4. 10 pence 4. 25,000 5. 10 pence 5. 25,000 6. 10 pence 6. 50,000 ------------ --------------------------- ----------------------------------- d) Aggregated information - Aggregated volume N/A - single transaction - Price --------------------------- ----------------------------------- e) Date of the transaction 28 August 2019 --------------------------- ----------------------------------- f) Place of the transaction London Stock Exchange, XLON --------------------------- -----------------------------------
Enquiries:
Intelligent Ultrasound www.intelligentultrasound.com Group plc Stuart Gall, CEO Tel: +44 (0)29 2075 6534 Cenkos Securities Tel: +44 (0)20 7397 8900 Giles Balleny (Nominated Adviser) Michael Johnson/Julian Morse (Corporate Broking) Walbrook PR Tel: +44 (0)20 7933 8780 or intelligentultrasound@walbrookpr.com Anna Dunphy/Paul McManus Mob: +44 (0)7876 741 001/Mob: +44 (0)7980 541 893
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DSHGIGDIBBDBGCI
(END) Dow Jones Newswires
August 28, 2019 04:12 ET (08:12 GMT)
1 Year Intelligent Ultrasound Chart |
1 Month Intelligent Ultrasound Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions